We have previously demonstrated that IL-1B in primary tumours correlates with future relapse in distal organs including bone in breast cancer patients [10] and have now demonstrated that IL-1B is altered between primary tumours and bone metastasis in cell lines and PDXs (Tables 3 and 4 and Fig. 6). Here, IL1B is linked to breast carcinoma.